Form 4 for PCVX Vaxcyte, Inc.
Accepted 2025-02-04 00:00:00 ET · period of report 2025-02-03 · accession 0001649094-25-000010 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2025-02-04 | 2025-02-03 | PCVX | Wassil Jim | COO | M - OptEx | $2.42 | +8,000 | 213.7K | +4% | +$19.4K |
| DM | 2025-02-04 | 2025-02-03 | PCVX | Wassil Jim | COO | S - Sale+OE | $86.23 | -8,000 | 208.4K | -4% | -$689.8K |
| D | 2025-02-04 | 2025-02-03 | PCVX | Wassil Jim | COO | M - OptEx | $0.00 | -8,000 | 2,638 | -75% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-02-03 | M | A | 8,000 | $2.42 | 213,695 | D | — | — | |
| 2 | Common | Common Stock | 2025-02-03 | S | D | 20 | $87.94 | 205,695 | D | — | — | |
| 3 | Common | Common Stock | 2025-02-03 | S | D | 2,666 | $86.67 | 205,715 | D | — | — | (F3) The price reported is a weighted-average price. The shares were sold at prices ranging from $86.365 to $87.10. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price. |
| 4 | Common | Common Stock | 2025-02-03 | S | D | 5,314 | $86.00 | 208,381 | D | — | — | (F2) The price reported is a weighted-average price. The shares were sold at prices ranging from $85.32 to $86.295. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price. |
| 5 | Derivative | Stock Option (right to buy) | 2025-02-03 | M | D | 8,000 | $0.00 | 2,638 | D | $2.42 · — to 2029-12-16 | 8,000 Common Stock | (F4) Option is fully vested and exercisable. |